Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Inari Medical Inc's Business Segments
Inari Medical Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
VTE
Total Revenue
$ 153
Regions Reported
1
Revenue Share by Reportable Segment - FY
- VTE95.3%
- Emerging Therapies5.3%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| VTE | $ 145 | 95.3% |
| Emerging Therapies | $ 8 | 5.3% |
Revenue Share by Region - FY
- Non-US7.6%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 12 | 7.6% |
Revenue by Product & Service Category - FY
- Venous Thromboembolism ("vte")95.3%
- Emerging Therapies5.3%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Venous Thromboembolism ("vte") | $ 145 | 95.3% |
| Emerging Therapies | $ 8 | 5.3% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- VTE95.3%
- Emerging Therapies5.3%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| VTE | $ 145 | 95.3% |
| Emerging Therapies | $ 8 | 5.3% |
Description of Inari Medical Inc
Inari Medical Inc. is a medical device company founded in 2013 and headquartered in Irvine, California. The company is dedicated to developing innovative technologies that improve the outcomes of patients with complex vascular disease. Inari Medical focuses on developing catheter-based intervention systems for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), which are the most common and serious forms of venous thromboembolism (VTE). The company's flagship product is the ClotTriever System, which is designed to remove large clot burdens from deep veins without the need for thrombolytic medication.
Inari Medical's ClotTriever System is a minimally invasive medical device that facilitates the rapid removal of large clots from deep veins in the legs. The device utilizes a vacuum-based system to physically remove the clot from the vein, which eliminates the need for thrombolytic drugs and reduces the risk of bleeding complications. The ClotTriever System is easy to use, and it can be performed in an outpatient setting with local anesthesia. This minimally invasive approach helps patients to recover more quickly and reduces the burden on hospitals.
Inari Medical has shown impressive growth in recent years, with the company's revenue increasing from $5 million in 2018 to $39 million in 2020. The company has attracted significant investment from venture capitalists, with two funding rounds raising a total of $234 million. In November 2020, Inari Medical completed an initial public offering (IPO) on the NASDAQ stock exchange, raising $156 million.
Inari Medical has also received regulatory approval from the U.S. Food and Drug Administration (FDA) for its ClotTriever System. The device was cleared for use in the United States in 2018, and further approvals have been granted in Europe, Japan, and other international markets. The company has also received several awards and recognitions for its innovation and impact on patient care.
Overall, Inari Medical is a rapidly growing medical device company that is dedicated to improving the outcomes of patients with complex vascular disease. With its innovative ClotTriever System, the company has demonstrated its ability to develop and market cutting-edge medical technologies that improve patient care, reduce healthcare costs, and enhance the quality of life for patients.
Inari Medical's ClotTriever System is a minimally invasive medical device that facilitates the rapid removal of large clots from deep veins in the legs. The device utilizes a vacuum-based system to physically remove the clot from the vein, which eliminates the need for thrombolytic drugs and reduces the risk of bleeding complications. The ClotTriever System is easy to use, and it can be performed in an outpatient setting with local anesthesia. This minimally invasive approach helps patients to recover more quickly and reduces the burden on hospitals.
Inari Medical has shown impressive growth in recent years, with the company's revenue increasing from $5 million in 2018 to $39 million in 2020. The company has attracted significant investment from venture capitalists, with two funding rounds raising a total of $234 million. In November 2020, Inari Medical completed an initial public offering (IPO) on the NASDAQ stock exchange, raising $156 million.
Inari Medical has also received regulatory approval from the U.S. Food and Drug Administration (FDA) for its ClotTriever System. The device was cleared for use in the United States in 2018, and further approvals have been granted in Europe, Japan, and other international markets. The company has also received several awards and recognitions for its innovation and impact on patient care.
Overall, Inari Medical is a rapidly growing medical device company that is dedicated to improving the outcomes of patients with complex vascular disease. With its innovative ClotTriever System, the company has demonstrated its ability to develop and market cutting-edge medical technologies that improve patient care, reduce healthcare costs, and enhance the quality of life for patients.
Inari Medical Inc. is a specialized medical technology company based in California, USA, focused on addressing the significant medical needs associated with venous thromboembolism (VTE). The company is dedicated to developing and commercializing innovative, minimally-invasive medical devices aimed at the treatment of conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari Medical is recognized for its commitment to improving patient care through its advanced technologies and its dedication to enhancing surgical workflow in the cardiovascular segment.
Segments
Inari Medical operates primarily within the medical device industry, focusing on the VTE market. The company’s main segment is:
- Minimally-Invasive Medical Devices for VTE Treatment: This includes devices specifically designed for removing blood clots from both deep veins and peripheral blood vessels, addressing critical aspects of DVT and PE. The emphasis is on making treatment procedures less invasive, thus promoting faster recovery times and reducing patient discomfort.
- Broader Cardiovascular Market: Inari Medical is expanding into adjacent areas within the cardiovascular field with innovative solutions aimed at addressing related conditions. This expansion reflects the companys strategy to broaden its impact within the interventional cardiology domain and to address a wider array of vascular complications.
Products
Inari Medicals product portfolio features a range of devices aimed at the effective and efficient management of VTE. The following are key products offered by the company:
1. FlowTriever System:
- This advanced thrombectomy device is designed for the removal of large blood clots from deep veins through a minimally invasive procedure, significantly decreasing reliance on traditional thrombolytic (clot-busting) therapies, which carry risks of bleeding and other complications.
2. ClotTriever System:
- The ClotTriever is engineered to remove thrombus from peripheral blood vessels, addressing conditions that can lead to DVT and potentially progressing to PE. The system employs a unique design to effectively engage and extract clots while minimizing damage to surrounding tissues.
3. Tweak System:
- This ancillary device is utilized alongside the ClotTriever System to enhance the engagement of the thrombus. The Tweak System improves the efficiency of clot removal by optimizing interaction with the thrombus, ensuring a thorough extraction process that enhances treatment outcomes.
4. FlexBridge System:
- The FlexBridge complements the FlowTriever System by providing additional structural support during the retrieval of clots located in deeper venous systems. This system allows for improved maneuverability and access, which can aid in successful thrombus removal.
Services
Inari Medical not only offers innovative medical devices but also a comprehensive suite of services aimed at enhancing the treatment experience for both physicians and patients. These services include:
- Physician Training and Education: Inari Medical provides thorough training programs for healthcare professionals, ensuring they are proficient in the use of its devices. These educational programs aim to enhance surgical skills and improve patient outcomes.
- Patient Education Materials: The company offers resources designed to inform patients about VTE, its treatment options, and what to expect during and after procedures. This educational support aims to empower patients regarding their health and recovery journey.
- Clinical Support: Inari Medical offers ongoing clinical support to healthcare providers throughout the entire treatment process, ensuring they have access to expertise and resources as needed. This assistance helps in addressing any complications that may arise and in optimizing procedural outcomes.
- Device Maintenance and Support: The company provides services related to the maintenance and operational support of its medical devices, ensuring they function properly and continue to meet clinical needs over time.
In summary, Inari Medical Inc. is at the forefront of developing minimally-invasive solutions for the treatment of venous thromboembolism and related cardiovascular conditions. With a comprehensive portfolio of innovative devices, bolstered by extensive training, educational resources, and clinical support services, Inari Medical is committed to enhancing patient care and outcomes in the vascular treatment landscape.
Segments
Inari Medical operates primarily within the medical device industry, focusing on the VTE market. The company’s main segment is:
- Minimally-Invasive Medical Devices for VTE Treatment: This includes devices specifically designed for removing blood clots from both deep veins and peripheral blood vessels, addressing critical aspects of DVT and PE. The emphasis is on making treatment procedures less invasive, thus promoting faster recovery times and reducing patient discomfort.
- Broader Cardiovascular Market: Inari Medical is expanding into adjacent areas within the cardiovascular field with innovative solutions aimed at addressing related conditions. This expansion reflects the companys strategy to broaden its impact within the interventional cardiology domain and to address a wider array of vascular complications.
Products
Inari Medicals product portfolio features a range of devices aimed at the effective and efficient management of VTE. The following are key products offered by the company:
1. FlowTriever System:
- This advanced thrombectomy device is designed for the removal of large blood clots from deep veins through a minimally invasive procedure, significantly decreasing reliance on traditional thrombolytic (clot-busting) therapies, which carry risks of bleeding and other complications.
2. ClotTriever System:
- The ClotTriever is engineered to remove thrombus from peripheral blood vessels, addressing conditions that can lead to DVT and potentially progressing to PE. The system employs a unique design to effectively engage and extract clots while minimizing damage to surrounding tissues.
3. Tweak System:
- This ancillary device is utilized alongside the ClotTriever System to enhance the engagement of the thrombus. The Tweak System improves the efficiency of clot removal by optimizing interaction with the thrombus, ensuring a thorough extraction process that enhances treatment outcomes.
4. FlexBridge System:
- The FlexBridge complements the FlowTriever System by providing additional structural support during the retrieval of clots located in deeper venous systems. This system allows for improved maneuverability and access, which can aid in successful thrombus removal.
Services
Inari Medical not only offers innovative medical devices but also a comprehensive suite of services aimed at enhancing the treatment experience for both physicians and patients. These services include:
- Physician Training and Education: Inari Medical provides thorough training programs for healthcare professionals, ensuring they are proficient in the use of its devices. These educational programs aim to enhance surgical skills and improve patient outcomes.
- Patient Education Materials: The company offers resources designed to inform patients about VTE, its treatment options, and what to expect during and after procedures. This educational support aims to empower patients regarding their health and recovery journey.
- Clinical Support: Inari Medical offers ongoing clinical support to healthcare providers throughout the entire treatment process, ensuring they have access to expertise and resources as needed. This assistance helps in addressing any complications that may arise and in optimizing procedural outcomes.
- Device Maintenance and Support: The company provides services related to the maintenance and operational support of its medical devices, ensuring they function properly and continue to meet clinical needs over time.
In summary, Inari Medical Inc. is at the forefront of developing minimally-invasive solutions for the treatment of venous thromboembolism and related cardiovascular conditions. With a comprehensive portfolio of innovative devices, bolstered by extensive training, educational resources, and clinical support services, Inari Medical is committed to enhancing patient care and outcomes in the vascular treatment landscape.